Iraq						                            
                            
						
 Research Article
												Effect of Erythropoietin Therapy on the Lipid Profile in Patients with Chronic Kidney Disease – A Single Center Study 						
Author(s): Ali J Hashim Al-Saedi, Sabah N Alwachi and Abdul Hakeem A KarimAli J Hashim Al-Saedi, Sabah N Alwachi and Abdul Hakeem A Karim             
						
												
				 Dyslipidemia is common in chronic kidney disease patients and alterations in serum lipid profile vary widely depending on the level of kidney function. We studied two hundred Iraqi patients who were diagnosed as having chronic kidney disease from June 2011 to January 2013. They were given erythropoietin for seven months. One hundred sixty patients (80%) showed response to treatment with an improvement in lipid profile, while the other 40 patients (20%) showed no significant response to treatment. In conclusion, treatment with erythropoietin seems to positively influence the lipid profile in patients with chronic kidney disease... Read More»
				  
												DOI:
												 10.4172/2161-0959.1000140 
																	  
Journal of Nephrology & Therapeutics received 784 citations as per Google Scholar report